Miami Neuro Symposium Evaluation - December 2, 2017

As a result of participating in this course, to what extent do you agree that you will be better able to accomplish these objectives *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice

	5	4	3	2	1	NA
Interventional Thrombectomy in Acute Stroke	Interventional Thrombectomy in Acute Stroke - 5	Interventional Thrombectomy in Acute Stroke - 4	Interventional Thrombectomy in Acute Stroke - 3	Interventional Thrombectomy in Acute Stroke - 2	Interventional Thrombectomy in Acute Stroke - 1	Interventional Thrombectomy in Acute Stroke - NA
Cite the evidence that shows endovascular thrombectomy is the standard of care for patients with emergent large-vessel occlusion.	Cite the evidence that shows endovascular thrombectomy is the standard of care for patients with emergent large-vessel occlusion. - 5	Cite the evidence that shows endovascular thrombectomy is the standard of care for patients with emergent large-vessel occlusion. - 4	Cite the evidence that shows endovascular thrombectomy is the standard of care for patients with emergent large-vessel occlusion. - 3	Cite the evidence that shows endovascular thrombectomy is the standard of care for patients with emergent large-vessel occlusion. - 2	Cite the evidence that shows endovascular thrombectomy is the standard of care for patients with emergent large-vessel occlusion. - 1	Cite the evidence that shows endovascular thrombectomy is the standard of care for patients with emergent large-vessel occlusion. - NA
Explain the results that led to guideline recommendations advocating for endovascular treatment in addition to t-PA.	Explain the results that led to guideline recommendations advocating for endovascular treatment in addition to t-PA. - 5	Explain the results that led to guideline recommendations advocating for endovascular treatment in addition to t-PA. - 4	Explain the results that led to guideline recommendations advocating for endovascular treatment in addition to t-PA. - 3	Explain the results that led to guideline recommendations advocating for endovascular treatment in addition to t-PA. - 2	Explain the results that led to guideline recommendations advocating for endovascular treatment in addition to t-PA. - 1	Explain the results that led to guideline recommendations advocating for endovascular treatment in addition to t-PA. - NA
Examine the feasibility and clinical value of high-resolution magnetic resonance vessel wall imaging for intracranial arterial stenosis. 5	Examine the feasibility and clinical value of high-resolution magnetic resonance vessel wall imaging for intracranial arterial stenosis. 5\|Evaluate the evidence of current stroke trials with regard to extending the window of treatment for some stroke patients. - 5	Examine the feasibility and clinical value of high-resolution magnetic resonance vessel wall imaging for intracranial arterial stenosis. 5\|Evaluate the evidence of current stroke trials with regard to extending the window of treatment for some stroke patients. - 4	Examine the feasibility and clinical value of high-resolution magnetic resonance vessel wall imaging for intracranial arterial stenosis. 5\|Evaluate the evidence of current stroke trials with regard to extending the window of treatment for some stroke patients. - 3	Examine the feasibility and clinical value of high-resolution magnetic resonance vessel wall imaging for intracranial arterial stenosis. 5\|Evaluate the evidence of current stroke trials with regard to extending the window of treatment for some stroke patients. - 2	Examine the feasibility and clinical value of high-resolution magnetic resonance vessel wall imaging for intracranial arterial stenosis. 5\|Evaluate the evidence of current stroke trials with regard to extending the window of treatment for some stroke patients. - 1	Examine the feasibility and clinical value of high-resolution magnetic resonance vessel wall imaging for intracranial arterial stenosis. 5\|Evaluate the evidence of current stroke trials with regard to extending the window of treatment for some stroke patients. - NA	Evaluate the evidence of current stroke trials with regard to extending the window of treatment for some stroke patients.
Describe relevant data linking stroke and cancer.	Describe relevant data linking stroke and cancer. - 5	Describe relevant data linking stroke and cancer. - 4	Describe relevant data linking stroke and cancer. - 3	Describe relevant data linking stroke and cancer. - 2	Describe relevant data linking stroke and cancer. - 1	Describe relevant data linking stroke and cancer. - NA
Explain a testable algorithm for cryptogenic stroke.	Explain a testable algorithm for cryptogenic stroke. - 5	Explain a testable algorithm for cryptogenic stroke. - 4	Explain a testable algorithm for cryptogenic stroke. - 3	Explain a testable algorithm for cryptogenic stroke. - 2	Explain a testable algorithm for cryptogenic stroke. - 1	Explain a testable algorithm for cryptogenic stroke. - NA
Recognize the potential risks associated with drug interaction commonly used in cancer treatment.	Recognize the potential risks associated with drug interaction commonly used in cancer treatment. - 5	Recognize the potential risks associated with drug interaction commonly used in cancer treatment. - 4	Recognize the potential risks associated with drug interaction commonly used in cancer treatment. - 3	Recognize the potential risks associated with drug interaction commonly used in cancer treatment. - 2	Recognize the potential risks associated with drug interaction commonly used in cancer treatment. - 1	Recognize the potential risks associated with drug interaction commonly used in cancer treatment. - NA
Identify the common causes and imaging manifestations of non-traumatic subarachnoid hemorrhage.	Identify the common causes and imaging manifestations of non-traumatic subarachnoid hemorrhage. - 5	Identify the common causes and imaging manifestations of non-traumatic subarachnoid hemorrhage. - 4	Identify the common causes and imaging manifestations of non-traumatic subarachnoid hemorrhage. - 3	Identify the common causes and imaging manifestations of non-traumatic subarachnoid hemorrhage. - 2	Identify the common causes and imaging manifestations of non-traumatic subarachnoid hemorrhage. - 1	Identify the common causes and imaging manifestations of non-traumatic subarachnoid hemorrhage. - NA
List the advantages and disadvantages of CT and MRI in non-traumatic subarachnoid hemorrhage.	List the advantages and disadvantages of CT and MRI in non-traumatic subarachnoid hemorrhage. - 5	List the advantages and disadvantages of CT and MRI in non-traumatic subarachnoid hemorrhage. - 4	List the advantages and disadvantages of CT and MRI in non-traumatic subarachnoid hemorrhage. - 3	List the advantages and disadvantages of CT and MRI in non-traumatic subarachnoid hemorrhage. - 2	List the advantages and disadvantages of CT and MRI in non-traumatic subarachnoid hemorrhage. - 1	List the advantages and disadvantages of CT and MRI in non-traumatic subarachnoid hemorrhage. - NA
Explain the advantages and disadvantages of CTA and MRA in non-traumatic subarachnoid hemorrhage.	Explain the advantages and disadvantages of CTA and MRA in non-traumatic subarachnoid hemorrhage. - 5	Explain the advantages and disadvantages of CTA and MRA in non-traumatic subarachnoid hemorrhage. - 4	Explain the advantages and disadvantages of CTA and MRA in non-traumatic subarachnoid hemorrhage. - 3	Explain the advantages and disadvantages of CTA and MRA in non-traumatic subarachnoid hemorrhage. - 2	Explain the advantages and disadvantages of CTA and MRA in non-traumatic subarachnoid hemorrhage. - 1	Explain the advantages and disadvantages of CTA and MRA in non-traumatic subarachnoid hemorrhage. - NA
Recognize the risks and benefits of different approaches based on patient and aneurysm characteristics.	Recognize the risks and benefits of different approaches based on patient and aneurysm characteristics. - 5	Recognize the risks and benefits of different approaches based on patient and aneurysm characteristics. - 4	Recognize the risks and benefits of different approaches based on patient and aneurysm characteristics. - 3	Recognize the risks and benefits of different approaches based on patient and aneurysm characteristics. - 2	Recognize the risks and benefits of different approaches based on patient and aneurysm characteristics. - 1	Recognize the risks and benefits of different approaches based on patient and aneurysm characteristics. - NA
Implement radiologic evaluation to determine the prognosis and treatment of subarachnoid hemorrhage.	Implement radiologic evaluation to determine the prognosis and treatment of subarachnoid hemorrhage. - 5	Implement radiologic evaluation to determine the prognosis and treatment of subarachnoid hemorrhage. - 4	Implement radiologic evaluation to determine the prognosis and treatment of subarachnoid hemorrhage. - 3	Implement radiologic evaluation to determine the prognosis and treatment of subarachnoid hemorrhage. - 2	Implement radiologic evaluation to determine the prognosis and treatment of subarachnoid hemorrhage. - 1	Implement radiologic evaluation to determine the prognosis and treatment of subarachnoid hemorrhage. - NA
Recognize the importance of radiologic interventional procedures for the management of this condition.	Recognize the importance of radiologic interventional procedures for the management of this condition. - 5	Recognize the importance of radiologic interventional procedures for the management of this condition. - 4	Recognize the importance of radiologic interventional procedures for the management of this condition. - 3	Recognize the importance of radiologic interventional procedures for the management of this condition. - 2	Recognize the importance of radiologic interventional procedures for the management of this condition. - 1	Recognize the importance of radiologic interventional procedures for the management of this condition. - NA
List the current cardiac indications and major adverse events associated with hypothermia.	List the current cardiac indications and major adverse events associated with hypothermia. - 5	List the current cardiac indications and major adverse events associated with hypothermia. - 4	List the current cardiac indications and major adverse events associated with hypothermia. - 3	List the current cardiac indications and major adverse events associated with hypothermia. - 2	List the current cardiac indications and major adverse events associated with hypothermia. - 1	List the current cardiac indications and major adverse events associated with hypothermia. - NA
Recognize the neuro indications for temperature modulations in the neuro ICU.	Recognize the neuro indications for temperature modulations in the neuro ICU. - 5	Recognize the neuro indications for temperature modulations in the neuro ICU. - 4	Recognize the neuro indications for temperature modulations in the neuro ICU. - 3	Recognize the neuro indications for temperature modulations in the neuro ICU. - 2	Recognize the neuro indications for temperature modulations in the neuro ICU. - 1	Recognize the neuro indications for temperature modulations in the neuro ICU. - NA
Implement prompt and effective evaluation and assessment of patients with stroke in order to reduce long-term effects associated with stroke.	Implement prompt and effective evaluation and assessment of patients with stroke in order to reduce long-term effects associated with stroke. - 5	Implement prompt and effective evaluation and assessment of patients with stroke in order to reduce long-term effects associated with stroke. - 4	Implement prompt and effective evaluation and assessment of patients with stroke in order to reduce long-term effects associated with stroke. - 3	Implement prompt and effective evaluation and assessment of patients with stroke in order to reduce long-term effects associated with stroke. - 2	Implement prompt and effective evaluation and assessment of patients with stroke in order to reduce long-term effects associated with stroke. - 1	Implement prompt and effective evaluation and assessment of patients with stroke in order to reduce long-term effects associated with stroke. - NA
Explain step-by-step algorithms for ICP crisis.	Explain step-by-step algorithms for ICP crisis. - 5	Explain step-by-step algorithms for ICP crisis. - 4	Explain step-by-step algorithms for ICP crisis. - 3	Explain step-by-step algorithms for ICP crisis. - 2	Explain step-by-step algorithms for ICP crisis. - 1	Explain step-by-step algorithms for ICP crisis. - NA
Define neurogenic stunned myocardium.	Define neurogenic stunned myocardium. - 5	Define neurogenic stunned myocardium. - 4	Define neurogenic stunned myocardium. - 3	Define neurogenic stunned myocardium. - 2	Define neurogenic stunned myocardium. - 1	Define neurogenic stunned myocardium. - NA
Recognize state medical strategies for poor-grade SAH management.	Recognize state medical strategies for poor-grade SAH management. - 5	Recognize state medical strategies for poor-grade SAH management. - 4	Recognize state medical strategies for poor-grade SAH management. - 3	Recognize state medical strategies for poor-grade SAH management. - 2	Recognize state medical strategies for poor-grade SAH management. - 1	Recognize state medical strategies for poor-grade SAH management. - NA

How effective were the following speakers in meeting their learning objectives? *

Scoring key: 5=Very effective, 4= Effective, 3= Somewhat effective, 2= Slightly effective, 1= Completely Ineffective Speakers are listed according to the lecture schedule.

	5	4	3	2	1	NA
High-Resolution Vessel Wall Imaging in Intracranial Arterial Disease - Daniel Mandell, M.D.	High-Resolution Vessel Wall Imaging in Intracranial Arterial Disease - Daniel Mandell, M.D. - 5	High-Resolution Vessel Wall Imaging in Intracranial Arterial Disease - Daniel Mandell, M.D. - 4	High-Resolution Vessel Wall Imaging in Intracranial Arterial Disease - Daniel Mandell, M.D. - 3	High-Resolution Vessel Wall Imaging in Intracranial Arterial Disease - Daniel Mandell, M.D. - 2	High-Resolution Vessel Wall Imaging in Intracranial Arterial Disease - Daniel Mandell, M.D. - 1	High-Resolution Vessel Wall Imaging in Intracranial Arterial Disease - Daniel Mandell, M.D. - NA
Update on Stroke Trials: Extending the Window - Blaise Baxter, M.D.	Update on Stroke Trials: Extending the Window - Blaise Baxter, M.D. - 5	Update on Stroke Trials: Extending the Window - Blaise Baxter, M.D. - 4	Update on Stroke Trials: Extending the Window - Blaise Baxter, M.D. - 3	Update on Stroke Trials: Extending the Window - Blaise Baxter, M.D. - 2	Update on Stroke Trials: Extending the Window - Blaise Baxter, M.D. - 1	Update on Stroke Trials: Extending the Window - Blaise Baxter, M.D. - NA
Stroke in the Cancer Patient - Felipe De Los Rios La Rosa, M.D.	Stroke in the Cancer Patient - Felipe De Los Rios La Rosa, M.D. - 5	Stroke in the Cancer Patient - Felipe De Los Rios La Rosa, M.D. - 4	Stroke in the Cancer Patient - Felipe De Los Rios La Rosa, M.D. - 3	Stroke in the Cancer Patient - Felipe De Los Rios La Rosa, M.D. - 2	Stroke in the Cancer Patient - Felipe De Los Rios La Rosa, M.D. - 1	Stroke in the Cancer Patient - Felipe De Los Rios La Rosa, M.D. - NA
Vessel Wall Imaging: Challenging Cases - Daniel Mandell, M.D.	Vessel Wall Imaging: Challenging Cases - Daniel Mandell, M.D. - 5	Vessel Wall Imaging: Challenging Cases - Daniel Mandell, M.D. - 4	Vessel Wall Imaging: Challenging Cases - Daniel Mandell, M.D. - 3	Vessel Wall Imaging: Challenging Cases - Daniel Mandell, M.D. - 2	Vessel Wall Imaging: Challenging Cases - Daniel Mandell, M.D. - 1	Vessel Wall Imaging: Challenging Cases - Daniel Mandell, M.D. - NA
Imaging for Subarachnoid Hemorrhage - Kevin Abrams, M.D.	Imaging for Subarachnoid Hemorrhage - Kevin Abrams, M.D. - 5	Imaging for Subarachnoid Hemorrhage - Kevin Abrams, M.D. - 4	Imaging for Subarachnoid Hemorrhage - Kevin Abrams, M.D. - 3	Imaging for Subarachnoid Hemorrhage - Kevin Abrams, M.D. - 2	Imaging for Subarachnoid Hemorrhage - Kevin Abrams, M.D. - 1	Imaging for Subarachnoid Hemorrhage - Kevin Abrams, M.D. - NA
New Endovascular Approaches to Unruptured Aneurysms - Italo Linfante, M.D.	New Endovascular Approaches to Unruptured Aneurysms - Italo Linfante, M.D. - 5	New Endovascular Approaches to Unruptured Aneurysms - Italo Linfante, M.D. - 4	New Endovascular Approaches to Unruptured Aneurysms - Italo Linfante, M.D. - 3	New Endovascular Approaches to Unruptured Aneurysms - Italo Linfante, M.D. - 2	New Endovascular Approaches to Unruptured Aneurysms - Italo Linfante, M.D. - 1	New Endovascular Approaches to Unruptured Aneurysms - Italo Linfante, M.D. - NA
Aneurysms and Subarachnoid Hemorrhages: State-of-the-Art Endovascular Treatment - Guilherme Dabus, M.D.	Aneurysms and Subarachnoid Hemorrhages: State-of-the-Art Endovascular Treatment - Guilherme Dabus, M.D. - 5	Aneurysms and Subarachnoid Hemorrhages: State-of-the-Art Endovascular Treatment - Guilherme Dabus, M.D. - 4	Aneurysms and Subarachnoid Hemorrhages: State-of-the-Art Endovascular Treatment - Guilherme Dabus, M.D. - 3	Aneurysms and Subarachnoid Hemorrhages: State-of-the-Art Endovascular Treatment - Guilherme Dabus, M.D. - 2	Aneurysms and Subarachnoid Hemorrhages: State-of-the-Art Endovascular Treatment - Guilherme Dabus, M.D. - 1	Aneurysms and Subarachnoid Hemorrhages: State-of-the-Art Endovascular Treatment - Guilherme Dabus, M.D. - NA
Temperature Management in the Neuro ICU - Kiwon Lee, M.D.	Temperature Management in the Neuro ICU - Kiwon Lee, M.D. - 5	Temperature Management in the Neuro ICU - Kiwon Lee, M.D. - 4	Temperature Management in the Neuro ICU - Kiwon Lee, M.D. - 3	Temperature Management in the Neuro ICU - Kiwon Lee, M.D. - 2	Temperature Management in the Neuro ICU - Kiwon Lee, M.D. - 1	Temperature Management in the Neuro ICU - Kiwon Lee, M.D. - NA
Medical Management After Stroke Intervention - Karel Fuentes, M.D.	Medical Management After Stroke Intervention - Karel Fuentes, M.D. - 5	Medical Management After Stroke Intervention - Karel Fuentes, M.D. - 4	Medical Management After Stroke Intervention - Karel Fuentes, M.D. - 3	Medical Management After Stroke Intervention - Karel Fuentes, M.D. - 2	Medical Management After Stroke Intervention - Karel Fuentes, M.D. - 1	Medical Management After Stroke Intervention - Karel Fuentes, M.D. - NA
Medical Management of Subarachnoid Hemorrhage - Kiwon Lee, M.D.	Medical Management of Subarachnoid Hemorrhage - Kiwon Lee, M.D. - 5	Medical Management of Subarachnoid Hemorrhage - Kiwon Lee, M.D. - 4	Medical Management of Subarachnoid Hemorrhage - Kiwon Lee, M.D. - 3	Medical Management of Subarachnoid Hemorrhage - Kiwon Lee, M.D. - 2	Medical Management of Subarachnoid Hemorrhage - Kiwon Lee, M.D. - 1	Medical Management of Subarachnoid Hemorrhage - Kiwon Lee, M.D. - NA

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

How many patients will you see in your practice who will likely be impacted by what you learned at this activity? *

1-5

6-10

Over 10

Not applicable to my practice

Is this your first time attending this symposium? *

Yes

No

How did you hear about us? *

Would you attend this symposium again next year? *

Yes

No

If you checked "No,” please tell us why: *

Would you recommend this symposium to a colleague? *

If you checked "No,” please explain why you would not recommend this course: *

What do you intend to do differently in the treatment of your patients as a result of what you learned? What new strategies will you apply in your practice of patient care? *

If you do not plan to implement any new strategies learned, please list any barriers or obstacles that might keep you from doing so.

Suggested topics and/or speakers you would like for future symposiums.

Comments

Name

You are here

Miami Neuro Symposium Evaluation - December 2, 2017